American International Group, Inc. Oncternal Therapeutics, Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.7 - $1.56 $15,380 - $34,276	-21,972 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.37 - $2.43 $2,118 - $3,756	-1,546 Reduced 6.57%	21,972 $31,000
Q4 2021 Feb 11, 2022	SELL	$2.27 - $4.39 $1,598 - $3,090	-704 Reduced 2.91%	23,518 $53,000
Q3 2021 Nov 12, 2021	SELL	$3.37 - $4.76 $1,941 - $2,741	-576 Reduced 2.32%	24,222 $101,000
Q2 2021 Aug 13, 2021	BUY	$4.75 - $9.39 $117,790 - $232,853	24,798 New	24,798 $118,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $80.5M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.